Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04496349
Title A Study Evaluating APG-115 as a Single Agent or in Combination With APG-2575 in Subjects With T-PLL
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Ascentage Pharma Group Inc.

prolymphocytic leukemia


APG-115 + APG-2575


Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.